The analysis of factors associated with progression of isolated terminal ileal lesions

PLoS One. 2014 Mar 13;9(3):e90797. doi: 10.1371/journal.pone.0090797. eCollection 2014.

Abstract

Objective: To assess the factors associated with the progression of isolated terminal ileal lesions (ITILs) at colonoscopy in Chinese patients.

Methods: Patients diagnosed with ITILs were enrolled. The ileoscopy was performed by two experienced gastroenterologists every 52 weeks. A logistic regression analysis was used to elucidate the factors associated with Crohn's disease (CD) and mucosal healing. A log rank test was used to assess the differences of the cumulative proportion of CD and mucosal healing in different groups at different times.

Results: (1) A total of 34 patients were included and no patient had taken nonsteroidal anti-inflammatory drug in the last 6 months; eight (23.5%) patients had a clinical diagnosis of CD, 14 (41.2%) patients achieved mucosal healing, and 12 (35.3%) patients showed no significant changes in the lesions at last follow-up. (2) The logistic regression analysis showed that only abdominal pain was a factor in the ITIL disease outcomes. (3) The cumulative proportion of CD in the abdominal pain group after 3 years was statistically higher than that in the non-abdominal pain group (42.7% vs. 6.2%, χ2 = 10.129, P = 0.001). However, the cumulative proportion of mucosal healing in the non-abdominal pain group was statistically higher than that in the abdominal pain group (73.3% vs. 5.6%, χ2 = 5.225, P = 0.022). (4) The numbers of lesions observed on the initial colonoscopy exams and the initial histologic findings were not related to the ITIL disease outcomes.

Conclusions: Clinical symptoms may be related to ITIL disease outcomes. Patients with abdominal pain had a high likelihood of CD, whereas those without abdominal pain had a high likelihood of mucosal healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Pain / etiology
  • Adult
  • China
  • Colonoscopy*
  • Crohn Disease / diagnosis*
  • Crohn Disease / drug therapy
  • Crohn Disease / pathology*
  • Disease Progression
  • Female
  • Gastroenterology
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Ileum / pathology*
  • Intestinal Mucosa / pathology*
  • Logistic Models
  • Male
  • Middle Aged
  • Prospective Studies
  • Regression Analysis
  • Treatment Outcome
  • Young Adult

Substances

  • Gastrointestinal Agents

Grants and funding

This study was sponsored by research funding for the doctoral program of higher education of China and the Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.